MedTrace Logo

The MEDIPSA Clinical Trial

NCT04588623 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2023-03-16

No results posted yet for this study

Summary

The main purpose of this study is to validate the positive effect of "Omnibiotic Stress Repair" on patients with active psoriatic Arthritis.

Conditions

Interventions

DIETARY_SUPPLEMENT

Omnibiotic Stress Repair (OBSR)

OBSR is given orally once daily (3g) for 3 months

OTHER

Placebo

Placebo is given orally once daily (3g) for 3 months

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-25
Primary Completion
2023-01-12
Completion
2023-03-14

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04588623 on ClinicalTrials.gov